A GPC1-targeted and gemcitabine-loaded biocompatible nanoplatform for pancreatic cancer multimodal imaging and therapy

Biomarker-targeted nanocarrier holds promise for early diagnosis and effective therapy of cancer. This work successfully designs and evaluates GPC1-targeted, gemcitabine (GEM)-loaded multifunctional gold nanocarrier for near-infrared fluorescence (NIRF)/MRI and targeted chemotherapy against pancreat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nanomedicine (London, England) England), 2019-09, Vol.14 (17), p.2339-2353
Hauptverfasser:	Qiu, Wenli, Zhang, Huifeng, Chen, Xiao, Song, Lina, Cui, Wenjing, Ren, Shuai, Wang, Yajie, Guo, Kai, Li, Donghui, Chen, Rong, Wang, Zhongqiu
Format:	Artikel
Sprache:	eng
Schlagworte:	gemcitabine GPC1 multimodal imaging targeted therapy theranostic nanoplatform
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!